Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Psychiatry Research|August 15, 2015
Striatal dopamine type 2 receptor availability in anorexia nervosaAllegra Broft, Mark Slifstein, Joseph Osborne, et al.Cancer|February 4, 2010
Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancerScott T Tagawa, Himisha Beltran, Shankar Vallabhajosula, et al.Translational Oncology|October 14, 2021
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional studyJuana Martinez, Kritika Subramanian, Daniel Margolis, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 13, 2011
Imaging inflammation in a patient with epilepsy due to focal cortical dysplasiaTracy Butler, Masanori Ichise, Andrew F Teich, et al.Scientific Reports|March 6, 2024
Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's riskLisa Mosconi, Schantel Williams, Caroline Carlton, et al.Cancer|April 24, 2019
Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177 Lu-J591) for metastatic castration-resistant prostate cancerScott T Tagawa, Shankar Vallabhajosula, Paul J Christos, et al.Alzheimer Disease and Associated Disorders|May 16, 2024
Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer DiseaseArsalan Haghdel, Natasha Smith, Lidia Glodzik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.AJNR. American Journal of Neuroradiology|November 6, 2025
Amyloid PET Z-score Quantification and correlation with visual semiquantitative gradingDivya Yadav, Ashley Knight-Greenfield, Joseph Moirano, et al.Leukemia & Lymphoma|April 16, 2014
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomabRebecca L Elstrom, Jia Ruan, Paul J Christos, et al.Pageof 3